Literature DB >> 3472076

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa.

F Clavel, K Mansinho, S Chamaret, D Guetard, V Favier, J Nina, M O Santos-Ferreira, J L Champalimaud, L Montagnier.   

Abstract

We recently reported the isolation of a new retrovirus, termed human immunodeficiency virus type 2 (HIV-2), from two West African patients with the acquired immunodeficiency syndrome (AIDS). This virus is related to but distinct from the well-characterized AIDS retrovirus, human immunodeficiency virus type 1 (HIV-1). We report here evidence of infection with HIV-2 in 30 patients, almost all from West Africa. Seventeen of them had a clinical syndrome indistinguishable from AIDS (7 of these 17 died). Others had either the AIDS-related complex or no HIV-related symptoms. All patients had serum antibodies reacting with HIV-2 in an indirect immunofluorescence assay. All serum tested contained antibodies reacting with the envelope glycoprotein of the virus in an immunoprecipitation assay. Cross-reactivity of serum antibodies with HIV-1 was detected in a minority of patients and varied according to the assay used. Retroviral isolates were obtained from the blood lymphocytes of 11 patients and were all identified as HIV-2 by nucleic acid hybridization; none hybridized with an HIV-1 probe. These findings indicate that some cases of AIDS in West Africa may be caused by HIV-2, but the extent of the spread of this virus and its clinical correlates will require careful epidemiologic investigation.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Antibodies--analysis; Biology; Data Analysis; Demographic Factors; Developing Countries; Diseases; Examinations And Diagnoses; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Physiology; Population; Population Characteristics; Research Methodology; Signs And Symptoms; Viral Diseases; Western Africa

Mesh:

Substances:

Year:  1987        PMID: 3472076     DOI: 10.1056/NEJM198705073161903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  53 in total

1.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

2.  HIV 1 and HIV 2 prevalence of seropositivity in a population of West Africa.

Authors:  N Zanchetta; P Viganò; G B Priuli; M P Ferrario; M Zago; A Pagano
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

3.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Computer predictions of functional, topogenic, and antigenic domains in human immunodeficiency virus-2 envelope glycoprotein.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1992-01       Impact factor: 2.332

5.  A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.

Authors:  J M Leiden; C Y Wang; B Petryniak; D M Markovitz; G J Nabel; C B Thompson
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat.

Authors:  Martine Peeters; Valerie Courgnaud; Bernadette Abela; Philippe Auzel; Xavier Pourrut; Frederic Bibollet-Ruche; Severin Loul; Florian Liegeois; Cristelle Butel; Denis Koulagna; Eitel Mpoudi-Ngole; George M Shaw; Beatrice H Hahn; Eric Delaporte
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

7.  Computer analysis of the amino acid sequences in gp41 of apathogenic African green monkey (AGM) virus, less pathogenic HIV-2 and highly pathogenic SIV and HIV-1 lentiviruses.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1992-11       Impact factor: 2.332

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  GLI-2 modulates retroviral gene expression.

Authors:  M J Smith; S D Gitlin; C M Browning; B R Lane; N M Clark; N Shah; S Rainier; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.